Uncategorized

A shift in medicine – why pharmaceutical companies are vying for the next blockbuster therapy – The Conversation – October 24, 2016

In recent years, there has been a shift in the focus of pharmaceutical companies, with the trend now focusing on discovering the next US$1billion “Blockbuster” medicine treatment for a rare disease state. In a new research piece published by online medical news site, The Conversation, researchers have identified that one of...

read more

Dummy group of undisclosed “experts” guillotining terminally ill patients’ treatment access before Christmas – MEDIA RELEASE – December 7, 2015

Dummy group of undisclosed “experts” guillotining terminally ill patients’ treatment access before Christmas An ‘Expert Reference Group’ (ERG) recently established by the Federal Health Minister to assess ongoing applications for a life-saving medication has rejected its first patient, leaving her to face an almost certain death.  Sarah Mulligan, 29, Cairns,...

read more

SMH – Trans-Pacific Partnership: Health groups say TPP will cost lives – October 6, 2015

The Trans-Pacific Partnership, or TPP, sets up a free-trade zone for forty percent of the world’s economy, and is considered the most ambitious trade pact in a generation. However, health experts are warning that the agreement, which was signed by 12 pacific-rim countries overnight, including Australia, could lead to “needless...

read more

‘Maddie Riewoldt’s Vision’ to raise awareness of Bone Marrow Failure Syndrome (BMFS) – June 15, 2015

In February, 2015, Madeleine Riewoldt, 26, sister to St Kilda (Australian Football League) Captain, Nick Riewoldt, tragically passed away from the rare bone marrow disease, aplastic anaemia, after a gruelling six year battle. Maddies’s story. Bone Marrow Failure Syndrome (BMFS) is a collection of medical conditions in which the bone...

read more